Imperial College London Featured PhD Programmes
University of Edinburgh Featured PhD Programmes
University of West London Featured PhD Programmes
Heriot-Watt University Featured PhD Programmes
University of Southampton Featured PhD Programmes
10 miles

University of Hull, Hull York Medical School PhD Projects, Programs & Scholarships

We have 9 University of Hull, Hull York Medical School PhD Projects, Programs & Scholarships

  • University of Hull
  • Hull York Medical School×
  • clear all
Order by 
Showing 1 to 9 of 9
  a-synuclein and SNARE complex. A new component of the platelet secretion machinery.
  Dr A Aburima
Application Deadline: 12 July 2019

Funding Type

PhD Type

A British Heart Foundation funded PhD studentship position is available to study the signal transduction pathways that regulate the function of blood platelets.
  Epidemiology of common endocrine disorders and diabetes
  Dr T Sathyapalan
Applications accepted all year round

Funding Type

PhD Type

A PhD project is available in Prof Sathyapalan group with a focus on the epidemiology of common endocrine disorders and diabetes at the University of Hull.
  How does the vascular matrix environment influence platelet activation?
  Dr S Calaminus
Application Deadline: 31 March 2020

Funding Type

PhD Type

The platelet is a blood cell that plays a key role in the prevention of bleeding. For platelets to form a clot or thrombus effectively, they must rearrange their actin cytoskeleton to withstand high shear stress from blood flow in the arteries.
  Identification of novel glucose-dependent alterations responsible for platelet dysfunction in Type 2 diabetes.
  Prof Tim Palmer, Dr F Rivero
Application Deadline: 31 March 2020

Funding Type

PhD Type

Type 2 diabetes mellitus (T2DM) is a growing global healthcare problem. Clinical findings suggest that more than 70% of patients with T2DM will die of cardiovascular diseases (CVDs) including heart attack and stroke.
  Identification of novel glucose-dependent alterations responsible for vascular dysfunction in Type 2 diabetes.
  Prof Tim Palmer, Dr R Sturmey
Application Deadline: 31 March 2020

Funding Type

PhD Type

Diabetes is a growing global healthcare problem. The majority of people living with diabetes have Type 2 diabetes mellitus (T2DM), characterised by a resistance of the body to the action of insulin.
  Investigating models of survivorship care for patients with haematological malignancie.
  Dr D Allsup
Application Deadline: 31 March 2020

Funding Type

PhD Type

The haematological cancers lymphoma, leukaemia and myeloma represent 8% of all cancers and collectively are the fifth commonest cancer.
  Modulation of platelet-mediated innate immune responses in chronic lymphocytic leukaemia
  Dr M Arman
Application Deadline: 31 March 2020

Funding Type

PhD Type

Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia in the Western World. B-cell receptor-induced intracellular signals are critical for the survival of leukaemia cells and disruption of this pathway by the Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib is a highly effective CLL therapy.
  Precision-cut lung slices to investigate the effect of human rhinovirus on cough and airway inflammation
  Dr L Sadofsky
Application Deadline: 31 March 2020

Funding Type

PhD Type

The human Rhinovirus (RV) is the major cause of the common cold. There are no current treatments or vaccines for the virus other than over the counter preparations to alleviate symptoms.
  Re-purposing diabetes medicines to manage bleeding complications in myeloproliferative neoplasms.
  Prof Tim Palmer, Dr D Allsup
Application Deadline: 31 March 2020

Funding Type

PhD Type

Myeloproliferative neoplasms (MPNs) are a group of three related blood cancers in which the bone marrow overproduces one of the three cellular components of blood (erythrocytes, leukocytes and platelets).
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2019
All rights reserved.